Police Killings Are The New National Crisis: These 4 Stocks Are Attracting Buy-And-Hold Investors In Droves

The Silicon Valley Insider would like to alert investors regarding several emerging investment opportunities that present unprecedented ongoing growth potential.

Global stocks have been reignited and have posted their best run since 2011. The Dow Jones Industrial Average, NASDAQ, S&P 500 and MSCI All Country World Index have served as the barometer for the rebound. Even the Stoxx Europe 600 Index is on track to have its best run since 2009. The rise in sentiment towards equities is also becoming a tremendous opportunity for companies that make police body cameras. In the middle of all this is the investor and the opportunity that has arisen to make sustained returns in this euphoria of equity growth. The emergence of police body cameras on the front lines of law enforcement is particularly interesting and is likely to make investors a lot of money over the next 20 years – don’t worry, you’ll be able to cash out much quicker than that with the four companies we found.

The police camera backstory is the fulcrum for any look-ahead to growth so it’s important that investors understand the moving parts that are contributing to the surge in demand for these devices. The public outcry started when unarmed teenager Michael Brown was shot and killed by police officer Darren Wilson in the St. Louis suburb of Ferguson in August last year. The death caused outrage, sending scores of protestors into the streets of Missouri.

Since the death of Michael Brown, several other unarmed citizens have died at the hands of police (979 such killings in 2015) and there is now overwhelming momentum to fit every single police officer in America with body cameras. President Obama has called for 50,000 police body cameras and a $263 million three-year spending program. The Department of Justice has joined in, announcing a $20 million funding program towards the effort.

Again, in the middle of all of this is the investor who’s been profiting diligently since the surge in demand for police cameras ensued. Shares in companies that make body cameras have erupted (in one case by as much as 739%) and we believe that the opportunity for sustained returns over the medium to long term will be a strong one. In other words, this is only the beginning. Body cameras will be the de facto silent arbitrator between police and citizens and investors who are savvy will be able to make outsized gains as they are deployed in the millions.

Here are our 4 must-have stocks in the police body camera market. We’ve assessed them for strength and growth outlook and they are listed as such. They range from most upside potential to least.

DirectView Holdings, Inc. (OTC: DIRV) is our small cap that we believe is positioned to provide investors with the greatest possible upside from this niche opportunity. In other words, DIRV is the most undervalued with the cheapest entry price per share – meaning you can load up the truck now, before it’s too late. DIRV provides surveillance and security solutions across 6 major markets. DIRV has serviced a roster of Fortune 500 clients and has been in the business for 19 years.

DIRV has several products in the market, but the reason we are tapping it to go big over the next 12 months is its flagship body camera – the DVXG-1000 Body-Worn Camera. The company has other models in the works.

The DVXG-1000 is one of the World’s First Body-Worn Smart Cameras in the U.S. and provides a tailored solution for the demanding needs of law enforcement. DIRV counts the New York Police Department as a client so the DVXG is already doing work on the ground.

The uptake so far of DIRV’s police body cameras bodes well for the company’s growth potential – not least because the video surveillance market is expected to reach $42.06 billion by 2020. That’s tremendous market potential and for a company making a cutting edge product, this is an exciting outlook all round.

Investors are already taking note of the growing profile of DIRV and its cutting edge security products. However, this is only the beginning of a prolonged bull market in this niche. Those smart enough to notice the opportunity now, will be rewarded.

DIRV signed a contract for approximately $300,000 with a New York based construction Management Company. It’s also moved swiftly to provide video and security solutions for the cannabis industry. A deal worth approximately $150,000, signed with a Colorado cannabis facility, drove home the commitment in August. DIRV also surprised investors with a deal signed for outfitting stores owned by Heels n More with surveillance equipment. The windfall from this deal could be substantial with plans of opening over 100 or so stores owned by Heels n More. Each store fitting will be worth $15,000 to DIRV.

To receive text Message alerts when new articles are released click here: http://clk2.it/k7oF5z

Follow us on Twitter: @Wealthy_VC

Like us on Facebook: www.facebook.com/WealthyVC


TASER International, Inc. (NASDAQ: TASR) is our mid-cap pick currently falling in the valuation range of $1 billion to $10 billion. TASR has naturally benefited from the intense media coverage of police killings and the demand for body cameras. Its shares rose in the wake of Ferguson. In response TASR has launched its new Axon Body 2 camera for $399 with unlimited HD storage included in the unlimited pricing tier for $79 per month. The HD component is a big deal for the market and Wall Street has responded well to the announcement.

TASR is also planning to ambush the in-car video market and plans to extend its Axon video and database platform. Coming in under $400, the disruptive entry is expected to generate strong market gains for TASR.

GoPro Inc. (NASDAQ: GPRO) is our next opportunity. You’ve probably watched the growth of this company. Since smashing in the tech doors and disrupting with its bestselling line of action cameras, GPRO has become a Wall Street poster company of sorts.

Since its IPO last year, it’s reached highs of $90 a share and has settled down to a valuation of more than $3.34 billion. That’s extraordinary for a company founded in 2002.

Even more extraordinary is the fact that GPRO seems to have virtually invented a market. Action cameras are now everywhere. They are even an important part of the exploding commercial drone market.

GPRO missed expectations on its last earnings call (EPS actual 25 cents vs EPS forecast 29 cents). 4 cents a share translates into roughly a $34 million revenue shortfall but some are upbeat. Is GPRO good value at current levels? We think so and would never put our foot in our mouth by counting out a company that has surged to as high as $90 a share. Neither should you. However, keep in mind, given the amount of attention it has already received from media to the investment public – much of the anticipated growth that we expect has already been priced in, in our opinion.

L-3 Communications Holdings Inc. (NYSE: LLL) is our large-cap (market cap is around $10.2 billion) and like TASR and GPRO, much of the upside has already been priced in, though we remain bullish. LLL supplies command and control, communications, intelligence, surveillance and reconnaissance systems and products, avionics, ocean products. A research of the company brings up similar names like Lockheed Martin, Raytheon and BAE Systems. Put another way, this is a serious heavy-hitter in the high stakes world of military grade technology and aerospace.

LLL is trading near $128 a share but has flirted with highs of $132 over the last 12 months. The company beat analyst expectations recently, posting third-quarter 2015 adjusted earnings of $2.09 per share.

LLL also injected some fresh legs into its executive, appointing Christopher Kubasik, a former Lockheed Martin Corp chief operating officer, as president and chief operating officer. Given that the position was newly created at LLL, we believe the company is digging in its heels for some serious strategic growth.

The Wealthy Biotech Trader is always researching new trade ideas which have the makings for large market moves. Traders are urged to follow our parent outlet, The Wealthy Venture Capitalist on social media (see below) to stay apprised. We are an anti-email media outlet, and as such will only be releasing our reports/ updates/ news through Twitter and Facebook as well as newswire.




To receive text Message alerts when new articles are released click here: http://clk2.it/k7oF5z

Follow us on Twitter: @Wealthy_VC

Like us on Facebook: www.facebook.com/WealthyVC

Email: Info@WealthyVentureCapitalist.com



This report/release/profile is a commercial advertisement and is for general information purposes only. We are engaged in the business of marketing and advertising companies for monetary compensation unless otherwise stated below. The Silicon Valley Insider and its employees are not a Registered Investment Advisors, Broker Dealers or a member of any association for other research providers in any jurisdiction whatsoever and we are not qualified to give financial advice. The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Sometimes human error can attribute to honest mistakes in reporting on issues regarding public companies and overall capital markets, and as such we are not responsible for the complete accuracy in these reports as the reader is required to verify all statements to ensure they are completely accurate. The Silicon Valley Insider encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled through their website, news releases, and corporate filings, or is available from public sources and Silicon Valley Insider makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies. The Private Securities Litigation Reform Act of 1995 provides investors a ‘safe harbor’ in regard to forward-looking statements.  Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact may be “forward looking statements”. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as “projects”, “foresee”, “expects”, “will”, “anticipates”, “estimates”, “believes”, “understands”, or that by statements indicating certain actions “may”, “could”, or “might” occur. Understand there is no guarantee past performance will be indicative of future results. Past Performance is based on the security’s previous day closing price and the high of day price during our promotional coverage.


The Silicon Valley Insider’s parent company has been and will be compensated $50,000 per month by DiriectView Holdings, Inc. The Silicon Valley Insider’s controlling parent company has also been compensated $100,000 by DirectView Holdings, Inc. in the form of a convertible note and readers should understand that they will convert this note into common shares sell them into the market as soon as the statutory 144 hold period has lapsed.


Readers must visit our website at www.wealthyventurecapitalist.com in order to view our entire disclaimer which covers most of the risks, biases and liability releases to have a full understanding after reading this article.

Related News

Leave a Reply

Your email address will not be published. Required fields are marked *

pour la musculation tamoxifen buylivraison anonyme, prix favorable As a rule, the infection occurs during penetrative sexual intercourse buy metronidazole no prescription moist environment and can remain viable. cialis 20mg rezeptfreider Wirkstoff des Arzneimittels wird nicht verlassen, Zweifel an der Wirksamkeit der Pillen ein bewährtes Medikament zur Behandlung von BPH in einer Dosierung von 10 mg, die Möglichkeit gibt, ein neues Potential des Penis, um zu versuchen buy Retin AThis drug will no doubt help to solve the problem with acne in young people from 16 years, thanks to the active ingredient of this cream you will experience relief, people will stop laughing at you Diagnosticare la causa della disfunzione erettilecomprar cilaiscosì spesso il trattamento può comportare molteplici tecniche. Comprar cialis en línea

Wealthy Venture Capitalist